The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Ulmus Macrocarpa Hance extract on lipid profile in adults with dyslipidemia for 12 weeks.
Previous another our study have indicated that Ulmus Macrocarpa Hance extract (UMH) may have the ability to decrease blood cholesterol. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the UMH on lipid profile in adults with dyslipidemia; the safety of the compound are also evaluate. The Investigators examine total cholesterol, HDL-cholesterol, triglyceridemia, LDL-cholesterol, and other biochemical parameters at baseline, as well as after 6 and 12 weeks of intervention. Eighty adults were administered either 500 mg of UMH or a placebo each day for 12 weeks;
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
80
Schisandra chinensis extract 500 mg/day for 12 weeks
Starch placebo 500 mg/day for 12 weeks
Integrated Research Institute for Natural Ingredients and Functional Foods
Yangsan, South Korea
LDL cholesterol
LDL cholesterol
Time frame: 12 weeks
Total cholesterol
Total cholesterol
Time frame: 12 weeks
Triglyceride
Triglyceride
Time frame: 12 weeks
HDL cholesterol
HDL cholesterol
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.